<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">It must be acknowledged that this overview is based on initial clinical and scientific reports. To date, there is paucity of information regarding the impact on the cardiovascular system and congenital heart defects population [
 <xref ref-type="bibr" rid="CR58">58</xref>]. Current therapeutic approaches to deal with the infection are mainly symptomatic and basic life support measures. Prevention aimed at reducing human-to-human transmission remains our best option.
</p>
